Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

被引:21
|
作者
Schaner, Marci E.
Davidson, Ben
Skrede, Martina
Reich, Reuven
Florenes, Vivi Ann
Risberg, Bjorn
Berner, Aasmund
Goldberg, Iris
Givant-Horwitz, Vered
Trope, Claes G.
Kristensen, Gunnar B.
Nesland, Jahn M.
Borresen-Dale, Anne-Lise [1 ]
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway
[2] Stanford Univ, Sch Med, Dept Biochem MES, Stanford, CA 94305 USA
[3] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[4] Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol & Expt Therapeut, IL-91120 Jerusalem, Israel
[5] Univ Oslo, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
关键词
D O I
10.1186/1476-4598-4-26
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: While numerous studies have characterized primary ovarian tumors, little information is available regarding expression patterns of metastatic sites of this cancer. To define sets of genes that distinguish primary and metastatic ovarian tumors, we used cDNA microarrays to characterize global gene expression patterns in 38 effusions ( 28 peritoneal, 10 pleural) and 8 corresponding primary ovarian tumors, and searched for associations between expression patterns and clinical parameters. Results: We observed multidimensional variation in expression patterns among the cancers. Coordinate variation in expression of genes from two chromosomal regions, 8q and 19q, was seen in subsets of the cancers indicating possible amplifications in these regions. A set of 112 unique genes of known function was differentially expressed between primary tumors and effusions using supervised analysis. Relatively few differences were seen between effusions isolated from the pleural and peritoneal cavities or between effusions from patients diagnosed with stage III and stage IV cancers. A set of 84 unique genes was identified that distinguished high from lower grade ovarian cancers. The results were corroborated using immunocytochemistry, mRNA in situ hybridization, and immunoblotting. Conclusion: The extensive variation in expression patterns observed underscores the molecular heterogeneity of ovarian cancer, but suggests a similar molecular profile for ovarian carcinoma cells in serosal cavities.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Microarray analysis of gene expression patterns in ovarian germ cell tumors
    Fritsch, M
    Schuster, AE
    Schneider, DT
    Perlman, EJ
    LABORATORY INVESTIGATION, 2001, 81 (01) : 2P - 2P
  • [42] Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data
    Abdallah, Reem
    Chon, Hye Sook
    Zgheib, Nadim Bou
    Marchion, Douglas C.
    Wenham, Robert M.
    Lancaster, Johnathan M.
    Gonzalez-Bosquet, Jesus
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (06) : 1000 - 1009
  • [43] Prognostic gene expression signature for high-grade serous ovarian cancer
    Millstein, J.
    Budden, T.
    Goode, E. L.
    Anglesio, M. S.
    Talhouk, A.
    Intermaggio, M. P.
    Leong, H. S.
    Chen, S.
    Elatre, W.
    Gilks, B.
    Nazeran, T.
    Volchek, M.
    Bentley, R. C.
    Wang, C.
    Chiu, D. S.
    Kommoss, S.
    Leung, S. C. Y.
    Senz, J.
    Lum, A.
    Chow, V
    Sudderuddin, H.
    Mackenzie, R.
    George, J.
    Fereday, S.
    Hendley, J.
    Traficante, N.
    Steed, H.
    Koziak, J. M.
    Kobel, M.
    McNeish, I. A.
    Goranova, T.
    Ennis, D.
    Macintyre, G.
    De Silva, D. Silva
    Ramon y Cajal, T.
    Garcia-Donas, J.
    Hernando Polo, S.
    Rodriguez, G. C.
    Cushing-Haugen, K. L.
    Harris, H. R.
    Greene, C. S.
    Zelaya, R. A.
    Behrens, S.
    Fortner, R. T.
    Sinn, P.
    Herpel, E.
    Lester, J.
    Lubinski, J.
    Oszurek, O.
    Toloczko, A.
    ANNALS OF ONCOLOGY, 2020, 31 (09) : 1240 - 1250
  • [44] Differential protein expression patterns in vaginal swabs of patients with high-grade serous ovarian cancer.
    Llaneza, Danielle C.
    Cornelison, Robert
    Petrova, Yuliya I.
    Dobbin, Zachary C.
    Maxwell, Larry
    Conrads, Thomas P.
    Landen, Charles N.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 90 - 90
  • [45] Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer
    Graf, Ryon P.
    Eskander, Ramez
    Brueggeman, Leo
    Stupack, Dwayne G.
    JAMA NETWORK OPEN, 2021, 4 (06) : E2114162
  • [46] Sequencing of SMAD4 somatic variation in patients with serous ovarian cancer
    Chen, A. P.
    Zhao, H. F.
    Ding, Z. X.
    Qi, Y. Y.
    Wang, C.
    Wang, J. L.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (01) : 85 - 88
  • [47] Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis
    Joel A Malek
    Alejandra Martinez
    Eliane Mery
    Gwenael Ferron
    Ruby Huang
    Christophe Raynaud
    Eva Jouve
    Jean-Paul Thiery
    Denis Querleu
    Arash Rafii
    Journal of Translational Medicine, 10
  • [48] Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis
    Malek, Joel A.
    Martinez, Alejandra
    Mery, Eliane
    Ferron, Gwenael
    Huang, Ruby
    Raynaud, Christophe
    Jouve, Eva
    Thiery, Jean-Paul
    Querleu, Denis
    Rafii, Arash
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [49] Expression Profile of Mucins in Ovarian Mucinous Tumors: Distinguishing Primary Ovarian from Metastatic Tumors
    Wang, Jayson
    El-Bahrawy, Mona A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2014, 33 (02) : 166 - 175
  • [50] Expression of Epithelial Cell Adhesion Molecule in Paired Tumor Samples of Patients With Primary and Recurrent Serous Ovarian Cancer
    Pietzner, Klaus
    Woopen, Hannah
    Richter, Rolf
    Joens, Thomas
    Braicu, Elena Ioana
    Dimitrova, Desislava
    Mellstedt, Hakan
    Darb-Esfahani, Silvia
    Denkert, Carsten
    Lindhofer, Horst
    Fotopoulou, Christina
    Sehouli, Jalid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (05) : 797 - 802